Requires informed consent for breast implant surgery.

This bill requires physicians in New Jersey to provide written informed consent information to patients before performing cosmetic breast implant surgery. It mandates that physicians share specific details including surgical risks, FDA-required manufacturer warnings, standardized information about breast implant-associated anaplastic large cell lymphoma (ALCL) and implant illness, and how to report adverse events via the FDA's MedWatch program. Patients must sign this written consent form prior to surgery. Physicians who fail to comply face disciplinary action, including potential license suspension or revocation. The bill directly affects all patients seeking breast implants and physicians performing this procedure in New Jersey.